ARTICLE | Distillery Therapeutics
Neurology
January 23, 2018 10:21 PM UTC
In vitro and mouse studies suggest a poly(A) oligonucleotide-based PABPC1 inhibitor could help treat pain. The oligonucleotide consisted of a poly(A) RNA oligonucleotide containing 2’-O-methyl ribose ...
BCIQ Company Profiles
BCIQ Target Profiles